Routine use of thiopurines in maintaining remission in pediatric Crohn's disease

World Journal of Gastroenterology

Volumn , Issue 27, 2014, Pages 9185-9190

  Boyle, Brendan M ^a   Kappelman, Michael D ^b   Colletti, Richard B ^c   Baldassano, Robert N ^d   Milov, David E ^e   Crandall, Wallace V ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e NEMOURS CHILDREN S HOSPITAL   (United States)

Author keywords

Crohn's disease; Mercaptopurine; Pediatric; Remission; Thiopurines

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; TACROLIMUS; ANTIINFLAMMATORY AGENT; GASTROINTESTINAL AGENT; STEROID;

ARTICLE; CHILD; CLINICAL PRACTICE; CROHN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEALTH PRACTITIONER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; REMISSION; TREATMENT OUTCOME; ADOLESCENT; AGE; BLOOD; CLINICAL TRIAL; DRUG MONITORING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REGISTER; SEVERITY OF ILLNESS INDEX; TIME; UNITED STATES;

6-MERCAPTOPURINE; ADOLESCENT; AGE FACTORS; ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; CHILD; CROHN DISEASE; DRUG MONITORING; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; REGISTRIES; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; STEROIDS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84905392630     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i27.9185     Document Type: Article

References (25)

1. Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011; 17: 423-439 [PMID: 20564651]
2. Kelsen J, Baldassano RN. Inflammatory bowel disease: the difference between children and adults. Inflamm Bowel Dis 2008; 14 Suppl 2: S9-S11 [PMID: 18816756]
3. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.e42; quiz e30 [PMID: 22001864 DOI: 10.1053/j.gastro.2011.10.001]
4. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980; 302: 981-987 [PMID: 6102739]
5. Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 1995; 37: 674-678 [PMID: 8549944]
6. Pearson DC, May GR, Fick G, Sutherland LR. Azathioprine for maintaining remission of Crohn's disease. Cochrane Database Syst Rev 2000; (2): CD000067 [PMID: 10796482]
7. Markowitz J, Grancher K, Kohn N, Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000; 119: 895-902 [PMID: 11040176]
8. Saibeni S, Virgilio T, D'Incà R, Spina L, Bortoli A, Paccagnella M, Peli M, Sablich R, Meucci G, Colombo E, Benedetti G, Girelli CM, Casella G, Grasso G, de Franchis R, Vecchi M. The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice. Dig Liver Dis 2008; 40: 814-820 [PMID: 18479986 DOI: 10.1016/j.dld.2008.03.016]
9. Reinisch W, Panés J, Lémann M, Schreiber S, Feagan B, Schmidt S, Sturniolo GC, Mikhailova T, Alexeeva O, Sanna L, Haas T, Korom S, Mayer H. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease. Am J Gastroenterol 2008; 103: 2284-2292 [PMID: 18671816 DOI: 10.1111/j.1572-0241.2008.02024]
10. Mantzaris GJ, Christidou A, Sfakianakis M, Roussos A, Koilakou S, Petraki K, Polyzou P. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease. Inflamm Bowel Dis 2009; 15: 375-382 [PMID: 19009634 DOI: 10.1002/ibd.20777]
11. Jaspers GJ, Verkade HJ, Escher JC, de Ridder L, Taminiau JA, Rings EH. Azathioprine maintains first remission in newly diagnosed pediatric Crohn's disease. Inflamm Bowel Dis 2006; 12: 831-836 [PMID: 16954801]
12. Punati J, Markowitz J, Lerer T, Hyams J, Kugathasan S, Griffiths A, Otley A, Rosh J, Pfefferkorn M, Mack D, Evans J, Bousvaros A, Moyer MS, Wyllie R, Oliva-Hemker M, Mezoff A, Leleiko N, Keljo D, Crandall W. Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis 2008; 14: 949-954 [PMID: 18306311 DOI: 10.1002/ibd.20412]
13. Lund JL, Cook SF, Allen JK, Carroll CF, Kappelman MD. Patterns of 6-mercaptopurine and azathioprine maintenance therapy among a cohort of commercially insured individuals diagnosed with Crohn's disease in the United States. Clin Epidemiol 2013; 5: 501-512 [PMID: 24348071 DOI: 10.2147/CLEP.S51625]
14. Riello L, Talbotec C, Garnier-Lengliné H, Pigneur B, Svahn J, Canioni D, Goulet O, Schmitz J, Ruemmele FM. Tolerance and efficacy of azathioprine in pediatric Crohn's disease. Inflamm Bowel Dis 2011; 17: 2138-2143 [PMID: 21910176 DOI: 10.1002/ibd.21612]
15. Goodhand JR, Tshuma N, Rao A, Kotta S, Wahed M, Croft NM, Sanderson IR, Epstein J, Rampton DS. Do children with IBD really respond better than adults to thiopurines? J Pediatr Gastroenterol Nutr 2011; 52: 702-707 [PMID: 21593643 DOI: 10.1097/MPG.0b013e31820ba46c]
16. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens G, Diamond RH, Broussard DL, Tang KL, van der Woude CJ, Rutgeerts P. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010; 362: 1383-1395 [PMID: 20393175 DOI: 10.1056/NEJMoa0904492]
17. Wennberg JE. Unwarranted variations in healthcare delivery: implications for academic medical centres. BMJ 2002; 325: 961-964 [PMID: 12399352]
18. Kappelman MD, Bousvaros A, Hyams J, Markowitz J, Pfefferkorn M, Kugathasan S, Rosh J, Otley A, Mack D, Griffiths A, Evans J, Grand R, Langton C, Kleinman K, Finkelstein JA. Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis 2007; 13: 890-895 [PMID: 17286275]
19. Colletti RB, Baldassano RN, Milov DE, Margolis PA, Bousvaros A, Crandall WV, Crissinger KD, D'Amico MA, Day AS, Denson LA, Dubinsky M, Ebach DR, Hoffenberg EJ, Kader HA, Keljo DJ, Leibowitz IH, Mamula P, Pfefferkorn MD, Qureshi MA. Variation in care in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2009; 49: 297-303 [PMID: 19590456 DOI: 10.1097/MPG.0b013e3181919695]
20. Crandall WV, Margolis PA, Kappelman MD, King EC, Pratt JM, Boyle BM, Duffy LF, Grunow JE, Kim SC, Leibowitz I, Schoen BT, Colletti RB. Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease. Pediatrics 2012; 129: e1030-e1041 [PMID: 22412030 DOI: 10.1542/peds.2011-1700]
21. Dubinsky MC, Lamothe S, Yang HY, Targan SR, Sinnett D, Théorêt Y, Seidman EG. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118: 705-713 [PMID: 10734022]
22. Prefontaine E, Sutherland LR, Macdonald JK, Cepoiu M. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009; (1): CD000067 [PMID: 19160175]
23. Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol 2004; 2: 731-743 [PMID: 15354273]
24. Hommel KA, Greenley RN, Maddux MH, Gray WN, Mackner LM. Self-management in pediatric inflammatory bowel disease: A clinical report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2013; 57: 250-257 [PMID: 23648790 DOI: 10.1097/MPG.0b013e3182999b21]
25. Hommel KA, Davis CM, Baldassano RN. Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 589-593 [PMID: 18985746 DOI: 10.1002/ibd.20798]